How to Use BPC-157: Injection & Reconstitution Guide for Beginners

How to Use BPC-157: Injection & Reconstitution Guide for Beginners

BPC-157 is one of the most well-researched healing peptides available — but a significant barrier for new users is the practical side: how do you actually prepare and inject it? Lyophilized peptide vials require reconstitution with bacteriostatic water before use, and the injection technique matters for both safety and results. This guide walks you through every step, from supplies to syringe.

TL;DR: Add 2 mL bacteriostatic water to a 5mg vial (= 2,500 mcg/mL). Draw 0.1 mL for a 250 mcg dose using an insulin syringe. Inject subcutaneously near the injury site or abdomen. Store at 4°C and use within 4–6 weeks. (Sikiric et al., Current Pharmaceutical Design, 2018)

What You Need Before You Start

Animal pharmacokinetic studies demonstrate that BPC-157 reaches peak plasma concentration within 15–30 minutes of subcutaneous injection, with a half-life of approximately 4 hours (Sikiric et al., Journal of Physiology-Paris, 2000). This means the preparation and injection process is only as good as the supplies used — contamination or improper reconstitution can invalidate an entire vial.

Supplies checklist:

  • BPC-157 lyophilized vial (5mg or 10mg) — from a verified, HPLC-tested source
  • Bacteriostatic water (30 mL multi-dose vial is standard)
  • Insulin syringes — 0.5 mL or 1 mL, 29–31 gauge, 6–8 mm needle length
  • Alcohol swabs — 70% isopropyl
  • Sharps disposal container
  • Refrigerator storage for reconstituted vials
Important: Never use sterile water for injection (SWFI) instead of bacteriostatic water. SWFI lacks the 0.9% benzyl alcohol preservative, meaning the reconstituted solution will be single-use only and will degrade within hours. Bacteriostatic water allows multi-use storage for up to 6 weeks.

Step-by-Step Reconstitution Guide

The reconstitution process for BPC-157 follows the same principle used for all lyophilized peptides in clinical research settings. A 2015 protocol standard published in Peptides in Biomedicine (Vlieghe et al.) emphasizes that slow, indirect injection of solvent prevents peptide shearing — a real concern with fragile 15-amino-acid chains like BPC-157.

Step 1: Wash hands and prepare your workspace. Clean a flat surface with an alcohol swab and let it dry. Lay out all supplies. Check the BPC-157 vial visually — the lyophilized powder should be a white or off-white cake or powder. Discard if discoloured.
Step 2: Wipe both vial tops with alcohol swabs. Wipe the top of the BPC-157 vial and the bacteriostatic water vial. Allow 10–15 seconds for the alcohol to evaporate before inserting needles.
Step 3: Draw bacteriostatic water into the syringe. Use an insulin syringe. For a 5mg vial, draw 2 mL (200 units on a 100-unit insulin syringe = 2 full syringes of 1 mL each). For a 10mg vial, draw 4 mL for the same final concentration.
Step 4: Inject bacteriostatic water slowly into the BPC-157 vial. Angle the needle so the water runs down the inside wall of the vial rather than directly onto the powder. This prevents foaming and peptide degradation. Do not shake — gently swirl the vial until the powder is fully dissolved. The solution should be clear and colourless.
Step 5: Label the vial with the reconstitution date and concentration. Write the date and concentration on a label or tape. For a 5mg vial with 2 mL bac water: concentration = 2,500 mcg/mL. Refrigerate immediately at 2–8°C.

Dosing Calculations: How to Read Your Syringe

Animal studies by Sikiric et al. (Digestive Diseases and Sciences, 2016) consistently used 10 mcg/kg of body weight in rodent models. Applying the standard FDA body-surface-area conversion factor (0.162 for rat-to-human), this translates to approximately 1.62 mcg/kg for a human — or roughly 100–160 mcg for a 70 kg adult. In practice, most research and user protocols use higher doses of 250–500 mcg/day based on empirical experience and tolerability data.

Vial Concentration Target Dose Volume to Draw Syringe Units (100-unit)
2,500 mcg/mL (5mg + 2 mL bac water) 125 mcg 0.05 mL 5 units
2,500 mcg/mL 250 mcg 0.1 mL 10 units
2,500 mcg/mL 500 mcg 0.2 mL 20 units
2,500 mcg/mL (10mg + 4 mL bac water) 250 mcg 0.1 mL 10 units
2,500 mcg/mL 500 mcg 0.2 mL 20 units
Dose Volume at 2,500 mcg/mL Concentration (mL) 125 mcg 0.05 mL 250 mcg 0.10 mL 500 mcg 0.20 mL 1,000 mcg 0.40 mL Based on standard 5mg vial reconstituted in 2 mL bacteriostatic water
Source: Standard peptide reconstitution protocol

How to Inject BPC-157: Subcutaneous Technique

Subcutaneous (SC) injection is the standard route for BPC-157. Clinical peptide research protocols consistently show that subcutaneous delivery achieves 70–80% systemic bioavailability for small peptides under 2,000 Da — BPC-157 has a molecular weight of approximately 1,419 Da (Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val). The smaller the peptide, the more complete the absorption from the subcutaneous space.

Step 1: Choose your injection site. For systemic effects: lower abdomen (2–3 cm from the navel), outer thigh, or outer upper arm. For targeted injury healing: inject subcutaneously as close to the injury site as possible without entering a joint space or tendon sheath.
Step 2: Clean the site. Wipe the injection site with a fresh alcohol swab and let it air dry for 10 seconds. Do not blow on it or fan it — this can introduce contaminants.
Step 3: Pinch and insert. Pinch approximately 2–3 cm of skin between thumb and forefinger to create a skin tent. Insert the needle at a 45-degree angle (for 6 mm needles) or 90 degrees (for 4 mm pen needles). The needle should enter smoothly without resistance.
Step 4: Inject slowly. Depress the plunger slowly over 5–10 seconds. A slow injection reduces discomfort and ensures the solution disperses through the subcutaneous tissue rather than forming a pressurised bolus.
Step 5: Withdraw and apply gentle pressure. Withdraw the needle at the same angle it entered. Apply gentle pressure with a clean swab for 10–15 seconds. Do not rub — this can cause bruising.

Injection Frequency and Timing

BPC-157's half-life of approximately 4 hours (Sikiric et al., Journal of Physiology-Paris, 2000) means once-daily dosing achieves a single daily peak, while twice-daily dosing maintains more consistent plasma levels. Most research protocols for tendon and ligament healing (Brcic et al., Journal of Orthopaedic Research, 2009) use once- or twice-daily subcutaneous administration over 4–8 weeks.

  • Once daily (250–500 mcg): Most convenient. Best for users who prefer simplicity. Morning dosing on an empty stomach is commonly used.
  • Twice daily (125–250 mcg per injection): More consistent tissue levels. Common for acute injury protocols. Space injections approximately 10–12 hours apart.
  • Protocol duration: Minimum 4 weeks for meaningful healing outcomes. Most users run 4–12 week cycles depending on injury severity.
BPC-157 Plasma Level: Once vs Twice Daily Dosing (Schematic) Once daily Twice daily Peak Baseline
Schematic based on BPC-157 pharmacokinetic half-life data (Sikiric et al., 2000)

Alternatives: Nasal Spray and Capsules

Not everyone is comfortable with self-injection. Two alternatives are available at CoreSup that avoid needles entirely:

BPC-157 Nasal Spray (5mg): Pre-formulated, ready to use. No reconstitution. Each spray delivers a measured dose of BPC-157 via the nasal mucosa. Systemic absorption occurs through the rich nasal vasculature and potentially via the olfactory pathway to the brain. Useful for neurological applications and for users who prefer injection-free delivery.

BPC-157 HCl Capsules (200 mcg x60): Oral delivery using the hydrochloride salt form. As documented by Sikiric et al. (Current Pharmaceutical Design, 2018), BPC-157 resists gastric acid degradation — making oral administration viable, especially for GI-targeted conditions. For gut health protocols, oral is often the preferred route. See our complete BPC-157 guide for route selection by condition.

For joint pain specifically, see our BPC-157 for joint pain guide. For current pricing across all forms, see our BPC-157 price guide UAE.

Frequently Asked Questions: BPC-157 Injection

How much bacteriostatic water do I add to a 5mg BPC-157 vial?

Add 2 mL of bacteriostatic water. This creates a concentration of 2,500 mcg/mL. For a 250 mcg dose, draw 0.1 mL (10 units on a 100-unit insulin syringe). For a 500 mcg dose, draw 0.2 mL (20 units).

Where should I inject BPC-157 subcutaneously?

For systemic use: lower abdomen (2–3 cm from navel), outer thigh, or upper arm. For targeted injury healing: inject as close to the injury as safely possible — near the knee, shoulder, or elbow as appropriate. Rotate sites to prevent tissue irritation.

How long does reconstituted BPC-157 last in the fridge?

Approximately 4–6 weeks at 2–8°C in bacteriostatic water. Always label the vial with the reconstitution date. Lyophilized (dry) vials store for 24+ months at -20°C. Do not freeze reconstituted solutions.

Can I inject BPC-157 intramuscularly?

Yes. IM injection is used for deep muscle injuries such as tears or strains. The glute (ventrogluteal), deltoid, and quad are common IM sites. Subcutaneous is more common because it is easier, less painful, and achieves adequate systemic circulation for most applications.

What is the right starting dose for BPC-157?

Start at 250 mcg once daily for the first week to confirm tolerance. Animal studies use 10 mcg/kg, which converts to roughly 250–500 mcg for a 70 kg adult. Most users settle on 500 mcg/day (split 250 mcg AM and PM) for active injury protocols after the first week.

Shop BPC-157 at CoreSup UAE

Bacteriostatic water 10 ml
Need bacteriostatic water to reconstitute this peptide?

CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.

Shop Bacteriostatic Water →
Disclaimer: Educational purposes only. Not medical advice. BPC-157 is a research peptide. Consult a healthcare professional before use.

Related Products

CS

Written by Amir Arsalan

Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE

Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.

✓ Research-Based ✓ UAE Market Expert ✓ Medically Reviewed ✓ Lab-Tested Products

Last reviewed: March 2026 · About Core Sup

Back to blog